Determining Circulating Tumour Cells (CTC) and other rare cells in cancer patients and for early detection screening
Not Applicable
Recruiting
- Conditions
- CancerChronic illness due to infectionCancer - Any cancerInfection - Studies of infection and infectious agents
- Registration Number
- ACTRN12614001143617
- Lead Sponsor
- Dr Karin Ried
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
treatment effectiveness: Patient diagnosed with cancer;
Have previously received (at least 3 weeks ago) or will receive treatment within one week;
treatment may include chemotherapy, radiotherapy, hyperthermia, intravenous Vitamin C, or other complementary treatment as prescribed by the treating physician;
Early detection screening: Patients with a family history of cancer or patients with chronic disease, or as part of a health check
Exclusion Criteria
no exclusion
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method